Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Opening Session Panel Discussion

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




May
06
Today In Oncology
Advanced CKM Syndrome Associated With Greater Cancer Risk
Integrated Molecular Analysis Identifies Determinants of Outcomes in TP53-Mutated DLBCL
Adjuvant Hepatic Arterial Infusion After Surgery for Four or More Colorectal Liver Metastases
Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the United States
AI Shows Dermatologist-Level Accuracy in Melanoma Diagnosis but Needs Validation
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo